Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy
Diabetes Mellitus, Diabetic Retinopathy, Vitreous Hemorrhage
About this trial
This is an interventional treatment trial for Diabetes Mellitus focused on measuring Diabetic retinopathy, Vitrectomy, Postoperative vitreous hemorrahge, Intravitreal gas injection
Eligibility Criteria
Inclusion Criteria: patients undergoing primary pars plana vitrectomy for complications of proliferative diabetic retinopathy were recruited for the prospective study Exclusion Criteria: (1) anticoagulant therapy had been used prior to surgery or during post-operative follow-up period; (2) positive medical history of blood diseases associated with abnormal blood coagulation.
Sites / Locations
- National Taiwan University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Study group
Control group
Group 1 had intravitreal long acting gas (10% C3F8) injection in the vitreous cavity at the end of surgery
Group 2 did not receive intravitreal long acting gas (10% C3F8)